Eric H. Reynolds
Known title: EVP - Chief Operating OfficerCIK: 0001631391
Associated companies
Transaction History
| CLX | ▼ Sell | Tax Withholding | 255 | $26K | 12/12/2025 | View on chart |
| CLX | ▲ Buy | Grant | 15,489 | $1.9M | 10/3/2025 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 2,755 | $337K | 10/3/2025 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 7,436 | $909K | 10/3/2025 | View on chart |
| CLX | ▲ Buy | Grant | 9,611 | $1.2M | 9/16/2025 | View on chart |
| CLX | ▲ Buy | Option Exercise | 15,210 | $1.7M | 9/4/2025 | View on chart |
| CLX | ▼ Sell | Open Market | 15,041 | $1.9M | 9/4/2025 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 283 | $46K | 12/19/2024 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 787 | $130K | 11/14/2024 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 550 | $89K | 10/4/2024 | View on chart |
| CLX | ▲ Buy | Grant | 12,205 | $2.0M | 10/4/2024 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 287 | $46K | 10/4/2024 | View on chart |
| CLX | ▲ Buy | Grant | 7,286 | $1.2M | 9/17/2024 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 160 | $27K | 9/13/2024 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 123 | $17K | 12/11/2023 | View on chart |
| CLX | ▲ Buy | Grant | 8,203 | $1.1M | 11/14/2023 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 801 | $100K | 10/5/2023 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 130 | $19K | 9/13/2023 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 173 | $25K | 9/13/2023 | View on chart |
| CLX | ▲ Buy | Grant | 5,523 | $814K | 9/13/2023 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 605 | $91K | 8/22/2023 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 74 | $11K | 12/1/2022 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 243 | $32K | 10/5/2022 | View on chart |
| CLX | ▲ Buy | Grant | 3,538 | $500K | 9/20/2022 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 160 | $23K | 9/13/2022 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 88 | $13K | 9/13/2022 | View on chart |
| CLX | ▲ Buy | Grant | 3,718 | $535K | 9/13/2022 | View on chart |
| CLX | ▼ Sell | Open Market | 585 | $91K | 5/9/2022 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 52 | $9K | 12/20/2021 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 171 | $28K | 9/22/2021 | View on chart |
| CLX | ▲ Buy | Grant | 2,808 | $460K | 9/21/2021 | View on chart |
| CLX | ▲ Buy | Grant | 1,861 | $318K | 8/19/2021 | View on chart |
| CLX | ▲ Buy | Grant | 909 | $156K | 8/19/2021 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 66 | $11K | 8/19/2021 | View on chart |
| CLX | ▼ Sell | Tax Withholding | 846 | $144K | 8/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Clorox Launches Purell ProCare Amidst Broader Consumer Stock Weakness
Clorox introduced its new Purell ProCare product line, adding to recent discussions about its digital expansion and innovation efforts. The stock is currently trading near its 52-week low, with an RSI of 31.1 indicating oversold conditions. Analysts maintain an average price target of $100.47, while the company offers a 3.40% dividend yield.
Clorox Launches Purell ProCare Amidst Broader Consumer Stock Weakness. Clorox introduced its new Purell ProCare product line, adding to recent discussions about its digital expansion and innovation efforts. The stock is currently trading near its 52-week low, with an RSI of 31.1 indicating oversold conditions. Analysts maintain an average price target of $100.47, while the company offers a 3.40% dividend yield.